Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$41.9M Buy
716,658
+169,314
+31% +$10.4M 0.03% 581
2014
Q2
$35.2M Buy
547,344
+29,975
+6% +$1.82M 0.03% 604
2014
Q1
$28.7M Buy
517,369
+40,539
+9% +$2.16M 0.03% 620
2013
Q4
$26.4M Buy
476,830
+29,025
+6% +$1.61M 0.02% 655
2013
Q3
$23.6M Buy
447,805
+135,682
+43% +$6.65M 0.02% 638
2013
Q2
$14M Buy
+312,123
New +$14.7M 0.02% 848

Other funds holding CE

UBS's CE Position: Q3 2014 in Review

UBS increased its Celanese (CE) stake by 31% in Q3 2014, buying an estimated $10.4M and bringing the position to 716,658 shares worth $41.9M. The position accounts for 0.03% of the portfolio, ranked #581.

UBS first reported a position in CE in Q2 2013 and has held it in 6 quarters since. 362 funds tracked by Wall St. Rank hold CE as of Q3 2014.

  • UBS held 716,658 shares of Celanese worth $41.9M as of Q3 2014.
  • UBS bought 169,314 Celanese shares in Q3 2014, an estimated $10.4M.
  • Celanese made up 0.03% of UBS's portfolio in Q3 2014, its #581 holding.
  • UBS first reported a position in Celanese in Q2 2013 and has held it in 6 quarters since.
  • 362 funds tracked by Wall St. Rank held Celanese as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.